Literature DB >> 24720458

Pediatric CKD and cardiovascular disease.

Osama Safder, Shafiqa Al sharif, Jameela A Kari1.   

Abstract

Children and adolescents with chronic kidney disease (CKD) are at high risk for cardiovascular morbidity and mortality. This review provides a comprehensive overview of the possible risk factors for early atherosclerosis in children with CKD. Endothelial dysfunction, a precursor of atherosclerosis, starts early in renal disease, as indicated by increased carotid artery intima media thickness, carotid arterial wall stiffness, impaired flow mediated dilatation, and coronary artery calcification, which are frequently present in children with CKD. Many risk factors for atherosclerosis, such as hypertension, dyslipidemia, renal bone disease, hyperhomocysteinemia, and uremia-related cardiovascular risk factors are associated with CKD. All of these risk factors are modifiable and optimal clinical management can delay or prevent cardiovascular disease. Another strategy to decrease the risk of premature cardiac disease and death in children with CKD is to slow the progression of renal disease.

Entities:  

Mesh:

Year:  2014        PMID: 24720458     DOI: 10.2174/1871529x14666140401112335

Source DB:  PubMed          Journal:  Cardiovasc Hematol Disord Drug Targets        ISSN: 1871-529X


  3 in total

1.  Impact of dyslipidemia on estimated glomerular filtration rate in apparently healthy children and adolescents: the CASPIAN-V study.

Authors:  Mohammad Moafi; Farahnak Assadi; Ramin Heshmat; Mehri Khoshhali; Mostafa Qorbani; Mohammad E Motlagh; Razieh Dashti; Majzoubeh Taheri; Roya Kelishadi
Journal:  World J Pediatr       Date:  2019-06-25       Impact factor: 2.764

2.  Primary Care Prescriptions of Potentially Nephrotoxic Medications in Children with CKD.

Authors:  Claire E Lefebvre; Kristian B Filion; Pauline Reynier; Robert W Platt; Michael Zappitelli
Journal:  Clin J Am Soc Nephrol       Date:  2019-12-12       Impact factor: 8.237

3.  Chronic kidney disease in children.

Authors:  Francesca Becherucci; Rosa Maria Roperto; Marco Materassi; Paola Romagnani
Journal:  Clin Kidney J       Date:  2016-06-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.